Skip to main content
Equibles

Commodore Capital LP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1831942 NEW YORK, NY
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$641,382
-$4,949,868 QoQ
Shares Held
2,788,620
+77.1% QoQ
Ownership
6.28%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 48 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. VTGN ranks #27 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RLAY
Relay Therapeutics, Inc.
 12,000,000 $224,520,000
2 ELVN
Enliven Therapeutics, Inc.
 3,275,000 $166,206,250
3 COGT
Cogent Biosciences, Inc.
 3,050,000 $118,035,000
4 DFTX
Definium Therapeutics, Inc.
 2,000,000 $94,080,000
5 SYRE
Spyre Therapeutics, Inc.
 846,786 $75,177,661
6 ANRO
Alto Neuroscience, Inc.
 2,723,196 $71,865,142
7 TNGX
Tango Therapeutics, Inc.
 2,250,000 $70,335,000
8 EYPT
EyePoint, Inc.
 4,600,000 $65,780,000

All Filings in VTGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $641,382 2,788,620
2025-09-30 $5,591,250 1,575,000
2025-06-30 $3,150,000 1,575,000
2025-03-31 $3,937,500 1,575,000
2024-12-31 $4,646,250 1,575,000
2024-09-30 $4,740,750 1,575,000
2024-06-30 $5,481,000 1,575,000
2024-03-31 $8,316,000 1,575,000
2023-12-31 $8,095,500 1,575,000
2023-09-30 $8,253,000 1,575,000
2022-06-30 $11,483,189 13,049,079
2022-03-31 $12,520,563 10,097,229
2021-12-31 $16,506,748 8,464,999
2021-09-30 $14,038,414 5,123,509
2021-06-30 $10,493,642 3,331,315
2021-03-31 $7,944,248 3,729,694
2020-12-31 $6,110,999 3,150,000